Advarra

JUNE 12, 2023

IBCs, however, seek to protect study personnel, the community, and the environment from exposure to engineered genetic material and other biohazardous agents. The IBC’s review is intended to ensure a thorough risk assessment is performed regarding the risks associated with the genetically modified materials.

Genetic Engineering 98

Genetic Engineering Gene Therapy Genetics Engineer 98

Advarra

AUGUST 31, 2022

A loaded syringe can be safely capped using either: A safety engineered syringe. All potentially infectious sharps must be disposed of in a biohazard sharps container immediately after use without recapping. Safety-engineered Syringes. The one-handed scoop technique. A recapping tool. Needles must not be bent or sheared.

Production 52

Production Biohazard Biohazard Containment 52

Advarra

OCTOBER 26, 2023

Controlled Environment and IP Containment The potential for a release, and the risk associated with a genetically engineered IP, are part of the IBC’s assessment purview under National Institutes of Health (NIH) Guidelines. And don’t forget to affix a biohazard sticker to the exterior for quick and clear identification.

Production 52

Production Containment Biohazard Biohazard 52

Advarra

JULY 28, 2022

In the case of IBC review, we’re preventing exposure to biologics such as engineered genetic materials and/or infectious agents. Work surfaces, such as the horizontal surface inside the BSCs, must be disinfected following work or spills involving biohazardous materials.

Contamination 52

Contamination Biohazard Biohazard Production 52